RAS mutated MCRC treatment

搜索文档
Cardiff Oncology(CRDF) - 2024 Q4 - Earnings Call Transcript
2025-02-28 06:30
Cardiff Oncology (CRDF) Q4 2024 Earnings Call February 27, 2025 04:30 PM ET Company Participants Kiki Patel - PrincipalMark Erlander - CEOJames Levine - Chief Financial OfficerAlexander Kelly - Biotech Equity Research Associate Conference Call Participants Joseph Catanzaro - Director & Senior Equity AnalystAndy Hsieh - Research AnalystRobert Burns - MD & Senior Healthcare AnalystAlbert Lowe - Senior Research Analyst Operator Welcome to the Cardiff Oncology Fourth Quarter twenty twenty four Financial Results ...